Total Payments
$6,361
2024 Payments
$99.00
Companies
9
Transactions
46
Medicare Patients
861
Medicare Billing
$93,524
Payment Breakdown by Category
Consulting$2,900 (45.6%)
Food & Beverage$1,606 (25.3%)
Travel$804.55 (12.6%)
Research$620.17 (9.7%)
Education$429.98 (6.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,900 | 1 | 45.6% |
| Food and Beverage | $1,606 | 37 | 25.3% |
| Travel and Lodging | $804.55 | 2 | 12.6% |
| Unspecified | $620.17 | 1 | 9.7% |
| Education | $429.98 | 5 | 6.8% |
Payments by Type
General
$5,741
45 transactions
Research
$620.17
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,997 | 5 | $0 (2022) |
| Eli Lilly and Company | $620.17 | 1 | $0 (2019) |
| Celgene Corporation | $440.10 | 17 | $0 (2019) |
| Janssen Biotech, Inc. | $429.98 | 5 | $0 (2024) |
| AbbVie Inc. | $279.03 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $259.39 | 4 | $0 (2023) |
| PFIZER INC. | $195.98 | 6 | $0 (2020) |
| Radius Health, Inc. | $121.35 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.91 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99.00 | 1 | Janssen Biotech, Inc. ($99.00) |
| 2023 | $308.92 | 3 | AbbVie Inc. ($109.85) |
| 2022 | $3,981 | 4 | Novartis Pharmaceuticals Corporation ($3,981) |
| 2021 | $147.72 | 5 | Janssen Biotech, Inc. ($79.99) |
| 2020 | $69.81 | 2 | Janssen Biotech, Inc. ($52.99) |
| 2019 | $1,458 | 19 | Eli Lilly and Company ($620.17) |
| 2018 | $160.76 | 3 | Radius Health, Inc. ($121.35) |
| 2017 | $135.74 | 9 | Celgene Corporation ($135.74) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 03/10/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 02/22/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $100.07 | General |
| Category: IMMUNOLOGY | ||||||
| 02/02/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $109.85 | General |
| Category: IMMUNOLOGY | ||||||
| 09/02/2022 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Consulting Fee | Cash or cash equivalent | $2,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2022 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Food and Beverage | In-kind items and services | $276.35 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2022 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Travel and Lodging | In-kind items and services | $210.15 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2022 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Travel and Lodging | In-kind items and services | $594.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2021 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA, SIMPONI ARIA | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 11/02/2021 | AbbVie Inc. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2020 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/14/2020 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA, SIMPONI ARIA | Education | In-kind items and services | $52.99 | General |
| Category: Immunology | ||||||
| 11/14/2019 | Eli Lilly and Company | — | — | In-kind items and services | $620.17 | Research |
| Study: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS | ||||||
| 11/11/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $29.96 | General |
| 11/04/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2019 | PFIZER INC. | CELEBREX (Drug), LYRICA | Food and Beverage | In-kind items and services | $35.68 | General |
| Category: INFLAMMATION;ONCOLOGY;PAIN | ||||||
| 10/25/2019 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Dermatology | ||||||
| 09/09/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/06/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS | Eli Lilly and Company | $620.17 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 184 | 252 | $44,152 | $18,150 |
| 2022 | 1 | 136 | 242 | $36,300 | $22,033 |
| 2021 | 7 | 280 | 341 | $49,657 | $31,538 |
| 2020 | 5 | 261 | 315 | $39,577 | $21,802 |
Total Patients
861
Total Services
1,150
Medicare Billing
$93,524
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 148 | $24,160 | $10,467 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 81 | 104 | $19,992 | $7,683 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 242 | $36,300 | $22,033 | 60.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 128 | 174 | $26,360 | $16,672 | 63.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 60 | 66 | $12,650 | $9,139 | 72.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 30 | 38 | $3,598 | $1,968 | 54.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $3,530 | $1,514 | 42.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 19 | $2,143 | $1,195 | 55.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $960.00 | $783.12 | 81.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $416.00 | $268.80 | 64.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 133 | 176 | $24,640 | $13,597 | 55.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 52 | 61 | $5,241 | $3,046 | 58.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 42 | $3,906 | $2,108 | 54.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 24 | 24 | $3,210 | $1,795 | 55.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $2,580 | $1,256 | 48.7% |
About Dr. Rama Atluri, M.D
Dr. Rama Atluri, M.D is a Rheumatology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063507531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rama Atluri, M.D has received a total of $6,361 in payments from pharmaceutical and medical device companies, with $99.00 received in 2024. These payments were reported across 46 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($2,900).
As a Medicare-enrolled provider, Atluri has provided services to 861 Medicare beneficiaries, totaling 1,150 services with total Medicare billing of $93,524. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Saint Louis, MO
- Active Since 10/03/2006
- Last Updated 01/15/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1063507531
Products in Payments
- ILARIS (Biological) $3,997
- TREMFYA (Drug) $330.98
- BENLYSTA (Biological) $259.39
- Otezla (Drug) $251.47
- RINVOQ (Biological) $177.58
- XELJANZ (Drug) $160.30
- Tymlos (Biological) $121.35
- Humira (Biological) $101.45
- REMICADE (Biological) $99.00
- CELEBREX (Drug) $35.68
- OFEV (Drug) $17.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Saint Louis
Dr. Alfred Kim, Md, MD
Rheumatology — Payments: $402,454
Rheumatology $402,454
Dr. Sona Kamat, M.d, M.D
Rheumatology — Payments: $266,392
Rheumatology $266,392
Dr. Adam Kilian, M.d, M.D
Rheumatology — Payments: $259,162
Rheumatology $259,162
Dr. Benjamin Schwartz, Md, MD
Rheumatology — Payments: $145,337
Rheumatology $145,337
Akgun Ince, M.d, M.D
Rheumatology — Payments: $55,223
Rheumatology $55,223
Dr. Sandra Hoffmann, M.d, M.D
Rheumatology — Payments: $29,229
Rheumatology $29,229